PROCR and Hyperglycemia: Procr+ progenitors can generate functional endocrine cells in vitro and in vivo, and islet organoids derived from Procr+ cells are capable of reversing hyperglycemia in a mouse model of streptozotocin-induced T1D (Wang et al., 2020).